Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Dogwood Therapeutics, Inc.
Market Cap
$53.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.01M
Operating Margin
-6056.37%
TTM Avg
-3556.76%
3Y Avg
-2097.71%
5Y Avg
-1497.54%
Market Cap
$52.99M
Operating Margin
N/A
TTM Avg
-19.41%
3Y Avg
-9.70%
5Y Avg
-6.47%
Market Cap
$51.72M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$54.90M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
Market Cap
$51.28M
Operating Margin
-61738.00%
TTM Avg
-183136.86%
3Y Avg
-98100.06%
5Y Avg
-86611.75%
Market Cap
$50.95M
Operating Margin
-9240.66%
TTM Avg
-8899.44%
3Y Avg
-6820.53%
5Y Avg
-4916.43%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | $53.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $53.01M | -6056.37% | -3556.76% | -2097.71% | -1497.54% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.99M | N/A | -19.41% | -9.70% | -6.47% |
| Microbot Medical Inc. (MBOT)vs › | $51.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| biote Corp. (BTMD)vs › | $51.61M | 18.50% | 17.27% | 3.29% | 10.87% |
| eXoZymes, Inc. (EXOZ)vs › | $51.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Apollomics, Inc. (APLM)vs › | $54.90M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| INmune Bio, Inc. (INMB)vs › | $51.28M | -61738.00% | -183136.86% | -98100.06% | -86611.75% |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | -9240.66% | -8899.44% | -6820.53% | -4916.43% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.10M | -90740.62% | -45413.43% | -22706.72% | -15137.81% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
